Effects of microRNA-346 on epithelial-mesenchymal transition in mouse podocytes

Gene

Volumn 560, Issue 2, 2015, Pages 195-199

  Xiao, Jing ^a,b,c   Liu, Dong ^a,b,c   Jiao, Wenju ^a,b,c   Guo, Jia ^a,b,c   Wang, Xiaoyang ^a,b,c   Zhang, Xiaoxue ^a,b,c   Lu, Shan ^a,b,c   Zhao, Zhanzheng ^a,b,c  

^a THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

^b ZHENGZHOU UNIVERSITY   (China)

^c Open Laboratory of Key Discipline of Clinical Medical Sciences   (China)

Author keywords

Epithelial mesenchymal transition; GSK 3 ; MiR 346; Podocyte

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; GLUCOSE; GLYCOGEN SYNTHASE KINASE 3BETA; MESSENGER RNA; MICRORNA; MICRORNA 346; NEPHRIN; UNCLASSIFIED DRUG; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA; MIRN346 MICRORNA, MOUSE;

3' UNTRANSLATED REGION; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LUCIFERASE ASSAY; MOUSE; NONHUMAN; PODOCYTE; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REAL TIME POLYMERASE CHAIN REACTION; ANIMAL; CELL CULTURE; ENZYME REPRESSION; GENE EXPRESSION; GENETICS; METABOLISM; PHYSIOLOGY; RNA INTERFERENCE;

ANIMALS; CELLS, CULTURED; ENZYME REPRESSION; EPITHELIAL-MESENCHYMAL TRANSITION; GENE EXPRESSION; GLYCOGEN SYNTHASE KINASE 3; MICE; MICRORNAS; PODOCYTES; RNA INTERFERENCE;

EID: 84923432303     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2015.02.001     Document Type: Article

References (23)

1. Alsaleh G., Suffert G., Semaan N., Juncker T., Frenzel L., Gottenberg J.E., Sibilia J., Pfeffer S., Wachsmann D. Bruton's tyrosine kinase is involved in miR-346-related regulation of IL-18 release by lipopolysaccharide-activated rheumatoid fibroblast-like synoviocytes. J. Immunol. 2009, 182:5088-5097.
2. Bartoszewski R., Brewer J.W., Rab A., Crossman D.K., Bartoszewska S., Kapoor N., Fuller C., Collawn J.F., Bebok Z. The unfolded protein response (UPR)-activated transcription factor X-box-binding protein 1 (XBP1) induces microRNA-346 expression that targets the human antigen peptide transporter 1 (TAP1) mRNA and governs immune regulatory genes. J. Biol. Chem. 2011, 286:41862-41870.
3. Bienz M. The subcellular destinations of APC proteins. Nat. Rev. Mol. Cell Biol. 2002, 3:328-338.
4. Cowie C.C., Port F.K., Wolfe R.A., Savage P.J., Moll P.P., Hawthorne V.M. Disparities in incidence of diabetic end-stage renal disease according to race and type of diabetes. N. Engl. J. Med. 1989, 321:1074-1079.
5. Cybulsky A.V. Endoplasmic reticulum stress in proteinuric kidney disease. Kidney Int. 2010, 77:187-193.
6. Farazi T.A., Juranek S.A., Tuschl T. The growing catalog of small RNAs and their association with distinct Argonaute/Piwi family members. Development 2008, 135:1201-1214.
7. Gambardella A., Nagaraju C.K., O'Shea P.J., Mohanty S., Kottam L., Pilling J., Sullivan M., Djerbi M., Koopmann W., Croucher P.I., Bellantuono I. Glycogen synthase kinase-3alpha/beta inhibition promotes in vivo amplification of endogenous mesenchymal progenitors with osteogenic and adipogenic potential and their differentiation to the osteogenic lineage. J. Bone Miner. Res. 2011, 26:811-821.
8. Kapinas K., Kessler C., Ricks T., Gronowicz G., Delany A.M. miR-29 modulates Wnt signaling in human osteoblasts through a positive feedback loop. J. Biol. Chem. 2010, 285:25221-25231.
9. Lee Y.J., Han H.J. Troglitazone ameliorates high glucose-induced EMT and dysfunction of SGLTs through PI3K/Akt, GSK-3beta, Snail1, and beta-catenin in renal proximal tubule cells. Am. J. Physiol. Renal Physiol. 2010, 298:F1263-F1275.
10. Liang Y., Ridzon D., Wong L., Chen C. Characterization of microRNA expression profiles in normal human tissues. BMC Genomics 2007, 8:166.
11. Mathieson P.W. Update on the podocyte. Curr. Opin. Nephrol. Hypertens. 2009, 18:206-211.
12. Meyer T.W., Bennett P.H., Nelson R.G. Podocyte number predicts long-term urinary albumin excretion in Pima Indians with Type II diabetes and microalbuminuria. Diabetologia 1999, 42:1341-1344.
13. Mundel P., Reiser J., Zúñiga Mejía Borja A., Pavenstädt H., Davidson G.R., Kriz W., Zeller R. Rearrangements of the cytoskeleton and cell contacts induce process formation during differentiation of conditionally immortalized mouse podocyte cell lines. Exp. Cell Res. 1997, 236:248-258.
14. Nirmalya D., Falguni D., Meenalakshmi M.M., Chandi C.M., Nandini G.C., Balakuntalam S.K., Goutam G.C. MicroRNA-21 orchestrates high glucose-induced signals to TOR complex 1, resulting in renal cell pathology in diabetes. J. Biol. Chem. 2011, 286:25586-25603.
15. Semaan N., Frenzel L., Alsaleh G., Suffert G., Gottenberg J.E., Sibilia J., Pfeffer S., Wachsmann D. MiR-346 controls release of TNF-alpha protein and stability of its mRNA in rheumatoid arthritis via tristetraprolin stabilization. PLoS ONE 2011, 6:e19827.
16. Susztak K., Raff A.C., Schiffer M., Böttinger E.P. Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy. Diabetes 2006, 55:225-233.
17. Toyoda M., Najafian B., Kim Y., Caramori M.L., Mauer M. Podocyte detachment and reduced glomerular capillary endothelial fenestration in human type 1 diabetic nephropathy. Diabetes 2007, 56:2155-2160.
18. Tuttle K.R. Linking metabolism and immunology: diabetic nephropathy is an inflammatory disease. J. Am. Soc. Nephrol. 2005, 16:1537-1538.
19. Valencia-Sanchez M.A., Liu J., Hannon G.J., Parker R. Control of translation and mRNA degradation by miRNAs and siRNAs. Genes Dev. 2006, 20:515-524.
20. Verzola D., Gandolfo M.T., Ferrario F., Rastaldi M.P., Villaggio B., Gianiorio F., Giannoni M., Rimoldi L., Lauria F., Miji M., Deferrari G., Garibotto G. Apoptosis in the kidneys of patients with type II diabetic nephropathy. Kidney Int. 2007, 72:1262-1272.
21. Wang Q., Wang Y., Minto A.W., Wang J., Shi Q., Li X., Quigg R.J. MicroRNA-377 is up-regulated and can lead to increased fibronectin production in diabetic nephropathy. FASEB J. 2008, 22:4126-4135.
22. Wang Q., Cai J., Cai X.H., Chen L. miR-346 regulates osteogenic differentiation of human bone marrow-derived mesenchymal stem cells by targeting the Wnt/beta-catenin pathway. PLoS ONE 2013, 8:e72266.
23. White K.E., Bilous R.W., Marshall S.M., El Nahas M., Remuzzi G., Piras G., De Cosmo S., Viberti G. Podocyte number in normotensive type 1 diabetic patients with albuminuria. Diabetes 2002, 51:3083-3089.